Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 531 | 215 | 219 | 217 | 186 |
| Gross Profit | 531 | 215 | 219 | 217 | 186 |
| Operating Expenses | 11,214 | 8,965 | 5,581 | 8,657 | 5,470 |
| Operating Income | -10,683 | -8,750 | -5,362 | -8,440 | -5,284 |
| Interest Expense | 3 | 1 | 2 | 3 | 2 |
| Other Income | 156 | 301 | 21 | 164 | 39 |
| Pre-tax Income | -10,530 | -8,450 | -5,343 | -8,279 | -5,247 |
| Net Income Continuous | -10,530 | -8,450 | -5,343 | -8,279 | -5,247 |
| Net Income | $-10,530 | $-8,450 | $-5,343 | $-8,279 | $-5,247 |
| EPS Basic Total Ops | -5.50 | -4.75 | -3.25 | -5.25 | -3.25 |
| EPS Basic Continuous Ops | -5.59 | -4.70 | -3.31 | -5.14 | -3.26 |
| EPS Diluted Total Ops | -5.50 | -4.75 | -3.25 | -5.25 | -3.25 |
| EPS Diluted Continuous Ops | -5.59 | -4.70 | -3.31 | -5.14 | -3.26 |
| EBITDA(a) | $-10,509 | $-8,604 | $-5,224 | $-8,233 | $-5,034 |